Financhill
Back

Structure Therapeutics Vs. Eli Lilly and Industry Stock Comparison

Sell
36

GPCR
Structure Therapeutics

Last Price:
39.63
Seasonality Move:
-19.39%
Buy
59

LLY
Eli Lilly and

Last Price:
917.50
Seasonality Move:
4.48%
Sell
36
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $38.99. The Score for GPCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Eli Lilly and (LLY) is a Buy

Is Eli Lilly and a Buy, Sell or Hold?

  • The current Eli Lilly and [LLY] share price is $916.42. The Score for LLY is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $38.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

LLY Stock Price Chart

What is Eli Lilly and's stock price today?

  • The Eli Lilly and share price today is $916.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 47.46 Sell
Chaikin Money Flow: 498645 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.5 - 42.7) Sell
Bollinger Bands (100): (35.36 - 45.62) Sell

LLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.96 Buy
Relative Strength Index (14 RSI): 52.22 Buy
Chaikin Money Flow: 1377335 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (893.87 - 926.35) Buy
Bollinger Bands (100): (843.7 - 937.96) Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.77 Buy
20-day SMA: 40.86 Sell
50-day SMA: 39.04 Sell
200-day SMA: 40.58 Sell
8-day EMA: 38.79 Buy
20-day EMA: 39.74 Sell
50-day EMA: 39.68 Sell
200-day EMA: 39.82 Sell

LLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 916.73 Sell
20-day SMA: 907.96 Buy
50-day SMA: 915.46 Buy
200-day SMA: 811.14 Buy
8-day EMA: 915.1 Buy
20-day EMA: 911.43 Buy
50-day EMA: 904.71 Buy
200-day EMA: 808.39 Buy

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Eli Lilly and Earnings Growth & LLY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.10 per share, and an increase next year of $9.43 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Eli Lilly and Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):